Long-term efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a prospective real-world cohort study in China by Yuyi Wang, Yuyi Wang, Yuyi Wang, Yuyi Wang, Ruiling Jia, Ruiling Jia, Ruiling Jia, Ruiling Jia, Qin Hu, Qin Hu, Qin Hu, Qin Hu, Xiao Tao, Xiao Tao, Xiao Tao, Xiao Tao, Qi He, Qi He, Qi He, Qi He, Guangying Luo, Guangying Luo, Guangying Luo, Guangying Luo, Qiong Xiong, Qiong Xiong, Qiong Xiong, Qiong Xiong, Zhongyu Zhang, Zhongyu Zhang, Zhongyu Zhang, Zhongyu Zhang, Yujuan Xiao, Yujuan Xiao, Yujuan Xiao, Yujuan Xiao, Yi Liu, Yi Liu, Yi Liu, Yi Liu

Get full text